Impact of cardiac biomarkers on heart failure risk prediction in the general population

11 May 2024 (08:00 - 20:00)

Organised by:

Sign in for access options

Sign in to view the resources

Sign in for access options

About the speaker

Doctor Caroline Morbach

University Hospital Wuerzburg, Wuerzburg (Germany)

5 More presentations in this session

Presentation thumbnail

Higher red blood cell distribution width is associated with worse outcomes in patients with chronic heart failure

Doctor L. Sensini (Rome, IT)

Abstract Slides Video

Presentation thumbnail

Predicting mortality in chronic heart failure: combined evaluation of VE/VCO2 and pVO2 independent of LVEF

Doctor J. Westphal (Jena, DE)

Abstract Slides Video

Presentation thumbnail

Impact of insulin therapy in diabetic patients hospitalized with acute heart failure

Doctor F. Bahouth (Nazareth, IL)

Abstract Slides Video

Presentation thumbnail

Cardiac amyloidosis in iceland: a nationwide epidemiologic study.

Doctor H. Johannsdottir (Reykjavik, IS)

Abstract Slides Video

Presentation thumbnail

I NEED HELP: unleashing the full potential of the acronym for the management of patients with heart failure and reduced ejection fraction

Doctor M. Paiva (Lisbon, PT)

Abstract Slides Video

Access the full session

Session thumbnail

Chronic heart failure - epidemiology, prognosis, outcome 9

The Event

Event poster

Heart Failure 2024

11 May - 14 May 2024

You may be interested in

Congress Presentation

Longitudinal changes in the prevalence of indicators for the precursor stage B of heart failure: results of the STAAB study

Congress Presentation

Risk, rates and BNP: refining thresholds in preclinical heart failure

Congress Presentation

Risk stratification in preclinical heart failure : identifying patients at high risk for heart failure hospitalization

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources